The mechanisms in which Foxp3+ T cells promoted HCC progression might include fostering angiogenesis (27), decreasing CD8+ T cells (32), progressively reducing CD4+ CTLs (31), and boosting the formation of portal vein tumor thrombi (PVTT) (29) and so on. The gene discussed is FOXP3; the disease is hepatocellular carcinoma.